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Canine influenza virus A (H3N2) is a newly emerged etiological agent for respiratory
infections in dogs. The mechanism of interspecies transmission from avian to canine
species and the development of diseases in this new host remain to be explored. To
investigate this, we conducted a differential proteomics study in 2-month-old beagles
inoculated intranasally with 106 TCID50 of A/canine/Guangdong/01/2006 (H3N2) virus.
Lung sections excised at 12 h post-inoculation (hpi), 4 days, and 7 days post-inoculation
(dpi) were processed for global and quantitative analysis of differentially expressed
proteins. A total of 17,796 proteins were identified at different time points. About
1.6% was differentially expressed between normal and infected samples. Of these,
23, 27, and 136 polypeptides were up-regulated, and 14, 18, and 123 polypeptides
were down-regulated, at 12 hpi, 4 dpi, and 7 dpi, respectively. Vann diagram analysis
indicated that 17 proteins were up-regulated and one was down-regulated at all three
time points. Selected proteins were validated by real-time PCR and by Western blot.
Our results show that apoptosis and cytoskeleton-associated proteins expression was
suppressed, whereas interferon-induced proteins plus other innate immunity proteins
were induced after the infection. Understanding of the interactions between virus and
the host will provide insights into the basis of interspecies transmission, adaptation, and
virus pathogenicity.
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Introduction
Waterfowl are natural reservoir hosts for influenza A virus, which maintain a vast viral
gene pool and pose a continued threat to humans and other mammalian species (Webster
et al., 1992). The unique agriculture practice and ecological systems in China and other east-
ern Asian countries have provided ample opportunities for avian influenza virus (AIV) to
cross species and cause sporadic infections in these mammalian hosts (Su et al., 2014a,b,c).
Due to the close contact with humans and frequent interactions with wandering animals,
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poultry and sometimes wildlife, companion pets (cats and dogs)
have been considered as potential “intermediate hosts” for the
interspecies transmission of zoonotic pathogens to humans.
Dogs are susceptible to multiple subtypes of influenza A
viruses. Interspecies transmission from human to dog or from
avian to dog has been repeatedly observed. Historically, dogs have
been reported to be infected with human seasonal H3N2, pan-
demic 2009 H1N1 viruses, equine H3N8, highly pathogenic avian
influenza virus (HPAI) H5N1, lowly pathogenic avian influenza
virus (LPAI) H9N2, and more recently, AIV H10N8 (Crawford
et al., 2005; Songserm et al., 2006; Sun et al., 2013, 2014; Su et al.,
2014b,d; Yin et al., 2014). Most of these belong to sporadic infec-
tions and the viruses could not become efficiently transmitted
among dogs. One of the exceptions was the epizootic caused by
an avian-origin H3N2 canine influenza virus (CIV). This was first
reported in 2008 among dogs being treated at veterinary clin-
ics in South Korea (Song et al., 2008). The H3N2 CIV infection
could be further traced back to 2006 when a highly related virus
was isolated in a sick pet dog in China (Li et al., 2010). This
virus has spread to other canine populations in eastern Asia and
even further to domestic cats (Lin et al., 2012; Su et al., 2013;
Sun et al., 2013b; Song et al., 2011). Serological findings of retro-
spective surveys suggested that the H3N2 virus might have been
circulating in canine populations in China for some time prior to
overt or reported epizootics (Zhao et al., 2011; Zhang et al., 2013).
Thus, available information has revealed that this H3N2 virus has
become established in canine population in these countries.
Introduction and establishment of an avian H3N2 influenza
virus in dogs have caused continuous prevalence in this host
species in Asia, which also raised concerns whether it could
become a sustained risk to the public and the veterinary health.
However, how did this avian-origin virus successfully establish
infection in the new canine host was unclear.
Many studies on the molecular basis for AIV to infect and to
adapt in mammalian species focused on viral genetic changes,
i.e., various non-synonymous substitutions occurred in the viral
genome such as Q226L and G228S in the hemagglutinin (HA)
(Connor et al., 1994), and E627K, M147L (Wang et al., 2012),
K339T (Liu et al., 2013), I588T (Foeglein et al., 2011), and K562R
(Song et al., 2014) in the PB2 protein. Studies focused on the host
response and the differential gene expression kinetics upon infec-
tion majorly used mouse or in vitro cell culture as the models
(Korth et al., 2013), and in recent years, ferrets were also used
(Bruder et al., 2010; Camp et al., 2012; Leon et al., 2013). As the
host of the newly established avian-origin H3N2 CIV, dogs served
as a unique model for the study of interspecies transmission and
adaptation of AIVs in mammals.
In this study, we conducted a global and quantitative
proteomics to identify host proteins that were differentially
expressed upon inoculation of the H3N2 CIV in dogs. We have
identified 278 host proteins that were differentially expressed at
different time points after inoculation. Selected up-regulated and
down-regulated proteins were validated by quantitative realtime
PCR (qPCR) and Western blot. Up-regulation of many inter-
feron (IFN)-induced proteins and other innate immune proteins
was identified. Down-regulation of proteins involved in apop-
tosis and cytoskeleton proteins was also identified. The role of
these positively and negatively induced proteins in relation to
pathogenicity and viral adaptation is discussed.
Materials and Methods
Virus and Viral Inoculation
CIV, A/canine/Guangdong/01/2006 (H3N2), was isolated from a
dogwith respiratory symptoms at an animal clinic in Guangdong,
2006 (Li et al., 2010). Virus stock was propagated in 10-day-old
embryonated chicken eggs and titrated using 1% horse erythro-
cytes. For in vivo virus inoculation, 2-month-old beagles (n = 9)
were used for inoculated and control groups, respectively. These
dogs were shown sero-negative by hemagglutination-inhibition
(HI) assay for seasonal influenza viruses (H1N1, H3N2, and
influenza B viruses) and for avian-origin CIV (H3N2). Inocula-
tion was conducted intranasally with 106 EID50 of the virus in
1.0ml phosphate buffered saline (PBS), under light anesthesia
by tiletamine–zolazepam (Virbac, 10–15mg/kg). For the control
group (n = 9), animals were mock inoculated with 1.0ml of PBS.
All animals, except for those euthanized for lung tissue collection,
were monitored daily for body temperature, virus shedding and
clinical signs for 14 days, and serum samples were collected at
14 dpi.
At 12 hpi, 96 hpi (4 dpi), and 168 hpi (7 dpi), two animals from
each group were euthanized by pentobarbital overdose. Lung tis-
sues were surgically removed and processed for detection of the
viral replication, hematoxylin-eosin (H&E) staining, immuno-
histochemistry examination and iTRAQ analysis. The lung tissue
samples from two dogs were analyzed individually. At 12 hpi, the
lobus cardiacus of right lungs from a dog was homogenated in
liquid nitrogen. At 4 and 7 dpi, lung tissues with lesions were
sampled in the lobus cardiacus of right lung in inoculated group
and the corresponding sites in the control group were chosen for
sampling and processing. Other parts of excised lung tissues were
collected for detection of the viral replication, hematoxylin-eosin
staining and immunohistochemistry.
Ethics Statement
All procedures in the animal experiments were approved by
the South China Agricultural University Experimental Animal
Welfare Ethics Committee with a reference number of 2014–05.
Histopathology and Immunohistochemistry of
the Lungs of Infected Dogs
Lung tissues were fixed first in 10% formalin, followed by
embedding in paraffin. Five-micrometer-thick (5µm) slices were
stained with hematoxylin-eosin and examined under an Olym-
pus DP70microscope (Olympus Corporation). A second set were
used for immunohistology, using rabbit anti-influenza A virus
nucleoprotein (NP) antibody (Serotech). Briefly, tissue sections
were de-paraffinized and then fixed with 100% chilled-acetone
for 2 h. The sections were incubated with 3% H2O2 for 15min at
37◦C before blocking with 5% bovine serum albumin (dilution in
PBS) for 1 h. The blocked sections were then incubated with rab-
bit anti-influenza A virus NP antibody (1:1000 dilution) at room
temperature for 1 h. The labeled tissue sections were stained with
horseradish peroxidase (HRP)-labeled goat anti-rabbit antibody
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(Sigma-Aldrich) and alkaline phosphatase substrate, and then
counterstained with hematoxylin QS (Vector Laboratories).
Sample Preparation, iTRAQ Labeling, and
Peptides Fractionation
Total protein samples were reduced and cysteine-blocked accord-
ing to the protocol provided by the manufacturer (iTRAQ kit,
Applied BioSystems). Samples were then 1:10 diluted in 0.5M tri-
ethylammonium bicarbonate (pH 8.5). Each sample was treated
with 1µg trypsin (25µl) and kept at 37◦C overnight. After the
samples were vacuum-dried, they were resuspended in 35µl
of 0.5M triethylammonium bicarbonate (pH 8.5). The non-
infected and infected samples were labeled with iTRAQ reagents
114 and 115, respectively. These labeled protein samples were
pooled and then purified using a strong cation exchange col-
umn. The bound peptides were eluted with 5% NH4OH in 30%
methanol.
After vacuum-dried, the iTRAQ-labeled peptides were recon-
stituted with 20µl of 5mM KH2PO4 containing 5% acetoni-
trile (pH 3.0), and separated via 2D-Liquid Chromatography
(2D-LC) with an Ultimate Dual-gradient LC system (Dionex
Ultimate3000).
Analysis of Liquid Chromatography Mass
Spectrometry (LC-MS)
The LC-MS analysis was performed on a Triple-TOF 5600 sys-
tem (AB SCIEX). Mass spectra were collected (m/z 400–1250) in
high resolution (> 30,000), using 250ms per spectrum. A maxi-
mum of 50 precursors in a cycle were selected for fragmentation
from each mass spectrum. Tandem mass spectra were harvested
in high sensitivity mode (resolution > 15,000).
The analyses of peptide and protein identifications and
iTRAQ quantification were performed on GPS Explorer soft-
ware (Applied Biosystems) using MASCOT search engine
(Matrix Science). The NCBI database (http://www.ncbi.
nlm.nih.gov/protein/?term=txid9615[Organism:noexp]) was
selected for analysis. Cysteine methane thiolation, iTRAQ-
labeled lysine, and N-terminal iTRAQ labeling were selected as
fixed modifications in the data analysis (Zieske, 2006).
Two-sample unequal variant-test was selected to analyze the
difference between mock-infected and infected samples. The dif-
ferent proteins were corresponded to a P-value< 0.05. Threshold
for iTRAQ was defined according to 95% CV+1.
Protein Pathway Analysis
Data were analyzed with IPA (Ingenuity Systems, http://www.
ingenuity.com), and proteins networks were constructed as
previously introduced (Munday et al., 2010). Briefly, differ-
entially identified proteins were uploaded into the IPA and
then corresponding genes were mapped using the Ingenu-
ity Pathways Knowledge Base. The connections between the
genes were further examined basing on the information of the
database. Graphical networks for these genes were constructed
basing on their connectivity algorithms. The nodes represented
genes or gene products. The color intensity of the node indi-
cates the relative decrease (green) or increase (red) abundance.
Different shapes of the nodes represent the functional class
of the gene. The nodes were linked based on the biological
relationships.
Real-Time RT-PCR
For the differently expressed proteins identified, selected proteins
with known sequence and function were validated by real-time
PCR. Lung tissue samples were homogenated in ice-cold PBS.
Total tissue RNA was extracted using the RNeasy Mini Kit (QIA-
GEN) following the manufacturers’ protocol. RNA concentra-
tions were measured by a spectrophotometer (260 nm/280 nm),
followed by generation of cDNA with Reverse-transcription
Kit (Invitrogen). Quantitative real-time PCR was performed
to determine the expression of GAPDH (glyceraldehyde-3-
phosphate dehydrogenase) gene and the targeted genes with
TaqMan Universal PCR Master Mix kit (Applied Biosystems).
After initial denaturation at 95◦C for 30 s, amplification was
conducted for 40 cycles with denaturation at 95◦C for 15 s,
primer annealing at 53◦C for 30 s, and DNA extension at
72◦C for 15 s. Primers used were: Annexin A2 forward: 5′-
CTATGATGCTGGAGTGAAGAG-3′ and reverse: 5′-GGAAAG
CATTTTCCAGGTCTC-3′; Caspase9 forward: 5′-ACATTGGTT
CTGGCGGAGCTC-3′ and reverse: 5′- TCACGGTCCAAGTTG
GAGCCC-3′; Mx1 forward: 5′-TGATATGCTGCACACGATA
AC-3′ and reverse: 5′-GATCTGCTCCATTTGGAAGTG-3′; Bcl-
xl forward: 5′-TGACATCCCAGCTTCACATCA-3′ and reverse:
5′-CTGCATCTCCTTGTCTACGCT-3′; GAPDH forward: 5′-
CATCACCATCTTCCAGGAGCG-3′ and reverse: 5′-AGATGA
TGACCCTTTTGGCT-3′.
Western Blot Analysis
For western blot analysis, total proteins from lung tissue samples
were extracted, and the protein concentration was determined
using the Bradford assay. Cell lysate (30µg) were fraction-
ated by 12% SDS-PAGE, followed by transferring to membranes
(GE Healthcare). After blocking with 5% non-fat dried milk,
the membranes were incubated, respectively with rabbit/mouse
monoclonal or polyclonal antibodies to GAPDH (ab9484),
Annexin A2 (ab41803), Caspase-9 (ab63488), Mx1 (ab95926),
and Bcl-xl (ab32670) (Abcam). The membranes were then sepa-
rately incubated with horseradish peroxidase (HRP)-conjugated
goat anti-mouse/rabbit IgG (used at 1:1000 dilutions, Santa
Cruz Biotechnology). The secondary antibody was detected with
enhanced chemiluminescence reagent (Thermo Scientific).
Statistical Analysis
Statistical significance of differences between groups was deter-
mined by using a paired, non-parametric Student’s t-test. P< 0.05
is considered as statistically significant.
Results
Experimental Infection with Canine H3N2
Influenza Virus in Dogs
All dogs inoculated with the CIV showed running nose, coughs,
and elevated body temperatures. The temperature peaked at
40.1◦C at 2 dpi (Figure 1A). Nasal swabs were collected from 1
to 14 dpi, viruses were detected from all infected dogs from 1 to 5
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FIGURE 1 | Pathology of dogs experimental infected with H3N2
canine influenza virus. Dogs were infected with 106 EID50 of virus
by intranasal inoculation. Rectal body temperature (A) and, the viral
titers (B) of nasal swabs were monitored for 14 days, and viral
replication in the lungs at 12 hpi, 4 dpi, and 7 dpi (C). Lung tissues
from infected or mock-infected dogs were stained with rabbit
anti-influenza A nucleoprotein (NP) antibody, HRP-labeled goat
anti-rabbit secondary antibody, and red alkaline phosphatase substrate
(D). Lung tissues from infected or mock-infected dogs were stained
with H&E stain (E).
dpi, and viral titers peaked at 4 dpi at 102.85 TCID50 (Figure 1B).
The viral replication of lung tissues were detected at 12 hpi, 4 dpi,
and 7 dpi, and themean viral titers of 12 hpi, 4 dpi, and 7 dpi were
1.21, 6.33, and 2.37 logTCID50/ml, respectively (Figure 1C).
Seroconversions were detected at 14 dpi (not shown). For the
gross pathology examinations, lesions were found in lungs of
infected dogs which were characterized by severe reddish consoli-
dation, especially involving the anterior lobes (not shown). Addi-
tionally, the lung tissues stained with the antibody which against
influenza A NP protein (obtained from Sigma-Aldrich) was pos-
itive mainly in pneumocytes (Figure 1D). The H&E staining
of the lung tissues showed interstitial pneumonia (Figure 1E).
These results showed that avian-origin CIV H3N2 could cause
respiratory diseases in the dogs experimentally inoculated with
the virus.
Identification of Differentially Expressed Lung
Proteins
To identify differentially expressed proteins, animals were euth-
anized at 12 hpi, 4 dpi, and 7 dpi, and their lung tissue
samples were collected for iTRAQ analysis. Relative protein
expression values were compared between infected and mock-
infected animals. A total of 17,796 proteins were detected and
quantified. The ratio of expression level of GAPDH, a refer-
ence control, was at equivalent between the levels from infected
and mock-infected dog samples. We further filtered statistically
significant proteins with the adjusted P-value < 0.05 (95% con-
fidence) (Figure 2A). Of these, 23, 27, and 136 proteins were
highly up-regulated with ratios ≥2 at 12 hpi, 4 dpi, and 7
dpi, respectively (Table S1) (Figure 2B), and 14, 18 and 123
were significantly down-regulated with ratios ≤0.5 (Table S1)
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FIGURE 2 | Distributions of total, up-regulated, and
down-regulated differential expressed proteins. Distributions of
total proteins ratio (A), analysis of up-regulated and down-regulated
proteins identified at different time points (B); distributions of
up-regulated (C) and down-regulated (D) proteins identified at
different time points as indicated.
(Figure 2B). As the infection progressed, the number of dif-
ferentially expressed proteins increased (Table S1) (Figure 2B).
Among the up-regulated proteins, 17 proteins were presented
at all three different time points (Table 1) (Figure 2). These
proteins included anti-viral proteins (OAS1-3, TRIM22, Mx1-2,
IFGGB1-2, ISG15, ISG20 and, pulmonary surfactant-associated
protein A-B) and proteins involved in antigen presentation and
signal transduction. The higher expression levels of these IFN
response-related genes were detected at 12 hpi and 4 dpi. At
day 7, the expression of these genes was lowered. Among the
down-regulated proteins, Calcyphosin was presented at all three
different time points (Table 1) (Figure 2D). Calcyphosin is a
calcium-binding protein, which may play a role in the regu-
lation of ion transport and may be associated with interstitial
lung disease. The MX (Horisberger et al., 1983; Kolb et al.,
1992; Haller et al., 1998), TRIM22 (Di Pietro et al., 2013), ISG15
(Hsiang et al., 2009), OAS (Hale et al., 2008), and SFTPA1, B
(Reading et al., 1997; Hartshorn et al., 2000) gene are impor-
tant effectors of innate immune response against viral infec-
tions. Up-regulation of IFN inducible proteins WARS and TAP1
(Coombs et al., 2010; Wu et al., 2013) has been reported previ-
ously, but their roles during influenza virus infection remain to be
clarified.
Subcellular and Functional Characterization of
Identified Proteins and Bioinformatics Analysis
To gain functional insights into the cellular proteome, these iden-
tified proteins were assigned to different molecular function and
subcellular annotations based on the biology evidence from the
UniProt KB/Swiss-Prot and TrEMBL protein database and from
the Gene Ontology database. We examined the subcellular local-
izations of the 278 identified proteins. These proteins (Figure 3A)
were localized in the cytoplasm (43.91%), nucleus (15.92%),
membrane (22.39%), mitochondrion (5.83%), membrane and
cytoplasm (5.73%), cytoskeleton (3.5%), mitochondrion and
nucleus (1.35%) and ribosome (1.37%).
Grouping of the previously characterized 278 proteins
revealed that their functions differed between up-regulated and
down-regulated proteins. Molecular and cellular functions, dis-
eases and disorders, physiological system development and
functions, and toxicity functions that were determined with
statistically significant levels (p = 0.05) are depicted in
Figures 3B–E. The 278 differentially expressed proteins cor-
respond to 25 diseases and disorders (Figure 3B), including
dermatological diseases and conditions, immunological dis-
eases, inflammatory diseases, inflammatory response, antimi-
crobial response, and infectious diseases. These proteins can
also be assigned to 28 molecular and cellular functional groups
(Figure 3C), including antigen presentation, protein synthesis,
cellular morphology, cellular assembly and organization, and
cell death; 24 physiological system development and func-
tional groups (Figure 3D), including hair and skin development
and function, hematological system development and func-
tion, tissue morphology, organ morphology, and skeletal and
muscular system development and function; and 49 toxicity
functions groups (Figure 3E), including liver hepatitis, renal
necrosis/cell death, cardiac proliferation, liver proliferation, and
renal damage.
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TABLE 1 | Summary of differentially expressed proteins presented at hour 12, day 4 and 7 post-inoculation.
Different proteins were defined with four specific functional
networks and each network contained at least eight mem-
bers. The four networks of interest correspond to: (1) cancer,
free radical, scavenging, dermatological disease and conditions
(Figure 4A); (2) cancer, developmental disorder, and muscular
and skeletal disorders (Figure 4B); (3) antimicrobial response,
inflammatory diseases and antigen presentation (Figure 4C); (4)
hematological disease, immunological diseases and infectious
disease (Figure 4D).
Validation of Transcriptional Profiles and Western
Blot of Differentially Expressed Proteins
To confirm the protein quantification, four proteins with altered
abundances (Annexin A2, Caspase9, Mx1, and Bcl-xL) were cho-
sen to validate the results. The transcriptional alterations of these
four selected genes in the infected lung tissues were analyzed. As
shown in Figure 5A, the trends in the change of the four genes’
mRNA levels in the infected and uninfected lung tissues were
similar to the changed patterns as what was observed in iTRAQ
analysis. To confirm the protein expression level of these four
genes of Annexin A2, Caspase-9, Mx1, and Bcl-xL during infec-
tion, equal amounts proteins were examined by Western blot
with corresponding specific antibodies (Figure 5B). The result
showed that the expression levels of Annexin A2 and Caspase9
in infected dogs were lower than that in controls, and the expres-
sion of Mx1 and Bcl-xL was higher than that in controls. These
data agreed with the results obtained in iTRAQ analysis.
Discussion
Interactions between virus and host during an infection involve
a complex interplay of host cellular and viral networks. To evade
host resistance and immunity, and to adapt to the new host, the
virus modulates various host cellular processes to increase viral
replication efficiency. On the other hand, for the host to achieve
anti-viral state, specific cellular processes are either activated
or suppressed. These changes are reflected by the differential
expression of cellular proteins. High-throughput quantitative
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FIGURE 3 | Continued
proteomics using iTRAQ is an idealmethod tomap such changes.
In addition, quantitation of differentially expressed proteins by
this technique is independent of the number of cells. Therefore,
it is well suited for studies using animal tissues or multi-cell
samples. However, as lung tissues usually contain heterogeneous
cell types and the protein expressions in different cells and
locations may vary, the proteomic analysis in this study can
only reflect the average level of gene expressions at the selected
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FIGURE 3 | Continued
lobus cardiacus in the right lungs of the inoculated dogs. Whole
genomic screening using single cell based techniques may help
to elucidate the differential expression of proteins in the different
pulmonary cells.
The time of 12 hpi was used to represent early infection when
the innate immune molecules began to identify the virus infec-
tion and launch the anti-viral response. At this time point, we
can find which innate immune molecules are involved. The time
of 4 dpi was the peak period for virus replication in the lungs. The
peak of viral replication may be due to the incomplete clearance
by innate immunity at early infection. Key anti-viral proteinsmay
be revealed at this time. Specific immunity would be started at
around 7 dpi to clear the virus. It was observed that at 12 hpi
and 4 dpi, the number and types of differently expressed peptides
were less than that at 7 dpi. This reflected the rapid and robust
inflammatory response induced at the early phase of the infec-
tion, and the decrease of relative level of most immune molecules
at 7 dpi. In addition, the most differentially expressed proteins
including signal transduction molecules, kinases and other bio-
chemical metabolism related enzymes, appeared at 7 dpi, and
may be associated with the repair of damaged lung tissues.
In this study, by characterizing the proteomics of infected
canine lungs in response to avian-origin CIV (H3N2), we have
identified cellular processes, such as gene expression, signaling
pathways and morphology altered by viral infection. A total of
278 differentially expressed proteins were identified, including
cellular proteins involved in cellular growth, proliferation,
assembly and organization, and apoptosis.
Frontiers in Microbiology | www.frontiersin.org 8 April 2015 | Volume 6 | Article 228
Su et al. Proteomic analysis of dogs infected by CIV
FIGURE 3 | Continued
These differentially expressed proteins correspond to 25
diseases and disorders such as dermatological conditions,
immunological diseases, inflammation, antimicrobial response,
and infectious diseases. Twenty-two proteins were involved in
dermatological diseases and conditions, which were identified as
most active during diseases and immune disorders models. Inter-
estingly, these differentially expressed proteins were not directly
involved in respiratory diseases or conditions. One implication
is that the clinical signs, such as fever and pneumonia in inoc-
ulated dogs were not a direct result of virus infection, but were
caused by the immune response, parallel to the “cytokine storm”
in severe clinical diseases (Julkunen et al., 2001; Tisoncik et al.,
2012), particularly in HPAI H5N1 infections (Seo et al., 2002).
Interferon (IFN) produced in response to pathogens, is an
extremely powerful component of the host innate immunity and
works as the first defense line against viral infection/replication.
Activation of IFN signaling pathways results in the production of
interferon-stimulated genes (ISGs), many of which have antiviral
activities. Indeed, many interferon induced proteins were up-
regulated after infection. Among these, the expression of Mx1,
Mx2, TRIM22,WARS, ISG15, ISG20, UBA7, DDX58, and OAS1-
3 were up-regulated, representing an increased innate immune
response against viral infections. The higher expression levels of
these interferon response-related genes were detected at 12 hpi
and 4 dpi, which may be associated with CIV infection-induced
inflammation. At 7 dpi the expression of these genes was lowered,
whichmay be associated with the inhibited replication of virus by
the host response.
A previous report has showed that these proteins in monkey
lungs involved in the innate immune response were up-regulated
after infection with influenza A virus [A/Texas/36/1991(H1N1)]
(Baas et al., 2006), and the trends of the protein expression were
consistent with those observed in our study. However, similar
results were not found in other proteomics research on mice
lungs infected with H5N1 (Zhao et al., 2012) and H9N2 (Qi et al.,
2015) AIV, and chicken brain infected with HPAI H5N1 (Zou
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FIGURE 3 | Subcellular localization of differentially expressed proteins (A), and functional characterization of up-regulated and down-regulated
proteins (B–E). (B) Diseases and disorders; (C) molecular and cellular functions; (D) physiological system development; (E) functions and toxicity functions.
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FIGURE 4 | Continued
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FIGURE 4 | Ingenuity pathway analysis (IPA) of differentially
expressed proteins. (A) Cancer, free radical, scavenging,
dermatological disease, and conditions; (B) Cancer, developmental
disorder, and muscular and skeletal disorders; (C) Antimicrobial
response, inflammatory diseases, and antigen presentation; (D)
Hematological disease, immunological diseases, and infectious disease.
Red, significantly up-regulated proteins; pink, moderately up-regulated
proteins; light green, moderately down-regulated proteins; dark green,
significantly down-regulated proteins; white, proteins known to be in the
network but not identified in our study.
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FIGURE 5 | Transcriptional modulation and Western blot confirmation
of representative proteins. CIV-infected canine lung tissues at 4 dpi are
harvested. (A) Total RNAs from infected/uninfected lung tissues were
measured by real-time RT-PCR analysis. Samples were normalized with the
GAPDH gene as the control housekeeping gene. (B) Expression of Annexin
A2, Caspase9, Bcl-xL, and Mx1 in CIV-infected canine lung tissues is
indicated by the Western blot. Expression of GAPDH in from different lung
samples was evaluated as a normalization method. Consistent results were
obtained by three independent experiments.
et al., 2010). The cellular proteomics data obtained from A549
cells infected with H3N2 swine influenza virus and H1N1 human
influenza virus showed that Mx1, Mx2, and ISG15 were up-
regulated and some cytoskeleton proteins were down-regulated
(Coombs et al., 2010; Dove et al., 2012; Wu et al., 2013).
Mx1 can prevent the vRNPs virus from being transported
to the nucleus (Xiao et al., 2013) as well as facilitating a direct
interaction with the between MxA and influenza A virus NP
protein (Zimmermann et al., 2011). Mx2 protein inhibits han-
tavirus (Jin et al., 2001) and HIV-1 (Goujon et al., 2013) but
not influenza virus replication. TRIM22 can inhibit RNA viruses
infection such as encephalomyocarditis virus (ECMV), hepatitis
B virus (HBV), human immunodeficiency virus type 1 (HIV-1)
and influenza virus (Di Pietro et al., 2013). IFN-induced antiviral
activity against influenza virus is by reducing protein synthesis
by 5 to 20-fold. This action is implemented by suppressing ISG15
conjugation (Hsiang et al., 2009). The genes WARS, OAS1-3,
ISG20, UBA7, and DDX58 (Figure 4C) showed a strong response
to CIV (H3N2) infection, but the effect on viral replication
remains to be determined. In addition, the pathway for antigen
presentation mediated by MHC class I was strongly induced by
CIV (H3N2) infection (Figure 4C). Many genes related to cellu-
lar immunity were also up-regulated; e.g., beta-2-microglobulin
(β2m), TAP1, TAP2, TAPBP, and IRGM. The function of β2m is
mainly in the stabilization of the tertiary structure of the MHC
class I to permit the presentation of antigenic peptides to CD8+
cytotoxic T lymphocytes (Yu et al., 2013). Transporter associated
with antigen presenting (TAP) 1 and TAP2 genes are localized
in the major histocompatibility complex (MHC) class II region
and can form a heterodimer. These proteins play a key role in
endogenous pathways for antigen presentation. Expression of
HLA-DQA1 was also up-regulated. Overall, these results show
that CIV (H3N2) infection induces a strong immune response.
Other differentially expressed proteins identified, such as sur-
factant protein A1 (SFTPA) and surfactant protein B (SFTPB),
were also up-regulated in our study. SFTPA and SFTPB can bind
to the polysaccharides of microorganisms and are considered
as an important function in innate immunity (Reading et al.,
1997). SFTPA and SFTPB can inhibit influenza viral infectivity
by binding to the viral HA or NA (Benne et al., 1997; Hartshorn
et al., 1997, 2000; Reading et al., 1997). Previously, Qi et al. has
demonstrated that the increased pathogenicity for LPAI H9N2
PB2 627K may be associated with SFTPA (Qi et al., 2015), but in
monkey lungs infected with H1N1, it was found that surfactant
protein D (SFTPD) was down-regulated (Baas et al., 2006). In
general, CIV (H3N2) infection activates both innate and adap-
tive immune response and the virus is eliminated quickly from
the host.
Infection of influenza virus in the respiratory tract causes
cell damage and induction of cytokines and chemokines. These
molecules trigger inflammatory and respiratory distress symp-
toms. Cell death is by apoptosis, which is characterized by specific
morphological changes, including disruption of cytoskeleton,
condensation of the cytoplasm and chromatin, membrane bleb-
bing, loss of mitochondrial function, and fragmentation of DNA.
As shown in Figure 4B, a variety of cytoskeleton-associated pro-
teins, such as actin, collagen, matrilin were down-regulated upon
infection with the CIV in dogs. Notably, HPAI H5N1 infection
in chicken caused the up-regulation of brain cytoskeleton (Zou
et al., 2010); H9N2 AIV infection in mice led to the decrease of
lung cytoskeleton proteins including moesin, ezrin, and myosin
et al (Qi et al., 2015).
Two other proteins associated with cell death and apopto-
sis, B-cell lymphoma-extra-large (Bcl-xL) and Caspase-9, were
identified as being up-regulated and down-regulated by CIV
(H3N2) infection. Bcl-xL is a member of the Bcl-2 protein fam-
ily whose main function is to promote cell survival; Caspase-9
can catalyze Caspase-3, Caspase-6, and Caspase-7. Caspase-7 can
activate the caspase cascade and promotes apoptosis. Influenza
virus-induced apoptosis may be a host defense mechanism (Xie
et al., 2009). However, lung tissue injury may also be associ-
ated with apoptosis. Therefore, induction of apoptosis is a host
defense mechanism by which the replication and spread of virus
is blocked. Inhibiting influenza virus-induced apoptosis by Bcl-2
expression reduces virus yield, virus spread, and glycosylation
of viral protein such as, the HA (Saito et al., 1996; Nencioni
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et al., 2009). Inhibition of apoptosis happened during CIV infec-
tion could limit virus replication and reduce the lung damage.
Compared to results obtained from the influenza virus-infected
A549 cells (Kroeker et al., 2012), it was showed that apoptosis
associated-proteins were down-regulated in both studies, though
the proteins related to cell death signaling were not exactly
the same.
Although complete genome of dogs has been sequenced
(Lindblad-Toh et al., 2005), full annotation remains to be com-
pleted. This study is a first attempt to combine high-throughput
analysis and the canine genome data to understand the molecular
basis of a newly emerged virus in the new host. Despite limitation
of known functions for many differentially expressed proteins,
our results provide informaion formore refined understanding of
interspecies transmission, viral pathogenesis, and host response.
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